Skip to search formSkip to main contentSkip to account menu

altiopril calcium

Known as: N-(3-N-cyclohexanecarbonyl-alanylthio)-2-(methylpropanoyl)proline calcium 
National Institutes of Health

Related topics

Related topics

1 relation

Narrower (1)

MC 838

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
Contribution of the tissue angiotensin converting enzyme to the antihypertensive effect of altiopril calcium (MC‐838) in spontaneously hypertensive rats
Abstract— The effect of a new orally active angiotensin converting enzyme (ACE) inhibitor, calcium (—)‐N‐[(S)‐3–[(N… 
1988
1988
Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
The antihypertensive effects of altiopril calcium (MC-838), calcium(-)-N-[(S)-3-[(N-cyclohexylcarbonyl-D-alanyl)thio]-2-methyl… 
1988
1988
Comparative cardiovascular effects of a novel angiotensin converting enzyme inhibitor altiopril calcium (MC-838) and captopril in spontaneously hypertensive rats.
The cardiovascular effects of a newly developed angiotensin converting enzyme (ACE) inhibitor, calcium(-)-N-[(S)-3-[(N… 
1987
1987
MC-838 (altiopril calcium): a novel orally active angiotensin converting enzyme inhibitor.
MC-838, calcium (-)-N-[(S)-3-(N-cyclohexylcarbonyl-D-alanyl) thio]-2-methylpropionyl]-L- prolinate, is a new orally active… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)